Tumor Ablation Market
The current Covid-19 pandemic has considerably influenced the microeconomic environments of several industries around the world to varying degrees. Tumor ablation market’s contours have heavily relied on the dynamics of the laboratory equipment market. Regulatory agencies, notably the WHO, are striving to bridge any scarcity of lab equipment so as not to hinder research and development activities. With the support of governments in various countries, they are coming with policy frameworks that support the healthcare sector in these difficult times of Covid-19. This will also have a profound effect on the growth of the tumor ablation market.
Several new, improved ablation techniques and staging systems have propelled the strides in the tumor ablation market. The growing preference of image-guided percutaneous ablation therapies over invasive surgeries is one of the key trends in the tumor ablation market. A promising application in the therapeutics is use of the modalities in hepatocellular carcinoma (HCC), one of the most common liver malignancies. The need for early staging of HCC is one of the accelerators of technological advances in the modalities such as the advent of high-end image-guided tumor ablation therapies. These trends have been supported by concomitant progress in diagnostic imaging and contrast agents. There is a need for detecting difficult to-detect HCC lesions. Advances in magnetic resonance imaging (MRI) and computed tomography (CT) techniques also play a role. This has helped in the prognosis of HCC. This has spurred the demand for RF ablations. Another area attracting research interest is MW ablation where a number of ex vivo and in vivo studies have been conducted. These have been looking at the underlying biological mechanisms. Real-time CT/MRI systems will expand the avenue for treatment avenues where tumor ablation is used. Another area which is gathering some traction is the use of devices in targeted drug research and gene therapy studies.
The market is anticipated to exhibit an exponential growth in the years to come. Rapid adoption of new type of treatment to fight cancer with better efficiency of tumor ablation against traditional therapies is favoring the tumor ablation market. Apart from this, increasing public awareness programs in order to detect cancer at a very first step along with funds provided by government of various countries for cancer research, particularly in developed countries is stoking the tumor ablation market.
However, it has been noticed that the exorbitant cost of tumor ablation techniques coupled with constraint subsidy scenarios is deterring the growth of the global tumor ablation market.
The global tumor ablation market, riding on multiple benefits is prognosticated to expand at 12.2% of CAGR during the forecast period 2017 – 2024.
The global tumor ablation market is classified on the basis of disease indication, technology, geography, and end user. On the basis of technology, the market is segregated into high-intensity focused ultrasound, radiofrequency ablation, microwave ablation, laser interstitial thermal, cryoablation, and others. Amongst them microwave ablation is the most popularized technology among the healthcare sector. Minimal side effects and less duration of therapy has made microwave ablation more favored technology. Cryoablation technology is the second most used technology after cryoablation. However, it has been noticed radiofrequency ablation technology is at present leading the market owing to the prolonged rise in liver cancer cases among population all over the world. Radiofrequency ablation technology held a whopping 35.6% of the market share in recent years.
On the basis of disease the, the global tumor ablation market is bifurcated into lung cancer, kidney cancer, breast cancer, bone cancer, prostate cancer, liver cancer, and others. Out of these, case of lung cancer is likely to grow at a staggering rate owing to rise in pollution and cigarette smoking level. It is predicted that this segment is likely to be valued at US$373.7mn by the end of the forecasts period. However, on the flip side, liver cancer registered 23.8% share in the overall market. According to WHO, in 2012, liver cancer became the primary reason of death for 745000 individual worldwide.
On the basis of end user, the global tumor ablation market can be split into cancer specialty clinics, hospitals, and others. Hospitals is known to record the highest number of footfalls owing to rising practices of visiting hospitals for well-being, coupled with presence of advanced facilities in hospitals. On the other hand, cancer specialty clinics is expected to beat hospitals on the base of growth rate due to rising preference towards cancer specialty clinics.
On the basis of geography, the market is segregated into Asia Pacific, Middle East and Africa, Latin America, Europe, and North America. Contribution by the U.S made North America to hold a staggering 34% of share in the overall market in recent years. Advanced healthcare facilities along with substantial awareness regarding the upcoming technologies for cancer has helped the market to grow in the region.
However, in coming years, Asia Pacific due to rapid urbanization, expansion of healthcare facilities, accompanied with rising disposable income is likely to provide better opportunities to the players in the market.
Some of the major players in the market are BVM Medical Limited, Sonacare Medical LLC, BTG Internation LET., and Medtronic plc.
1. Preface
2. Research Methodology & Assumptions
3. Executive Summary
4. Global Tumor Ablation Products Market Overview
4.1 Introduction (Product Definition)
4.2 Industry Evolution/Development
4.3 Key Market Indicators
4.4 Market Dynamics
4.4.1 Drivers
4.4.2 Restraints
4.4.3 Opportunity
4.5 Global Market Analysis and Forecasts, 2014 – 2024
4.6 Global Market - Global Supply Demand Scenario
4.7 Porter’s Five Force Analysis
4.8 Value Chain Analysis
4.9 Market Outlook
5. Global Tumor Ablation Market Analysis and Forecast by Technology
5.1 Key Findings
5.2 Introduction
5.3 Market Size (US$ Mn) Forecast, By Technology
5.3.1 Radiofrequency Ablation
5.3.2 Microwave Ablation
5.3.3 Cryoablation
5.3.4 High-Intensity Focused Ultrasound
5.3.5 Laser Interstitial Thermal Ablation
5.3.6 Others
5.4 Market Attractiveness, By Technology
5.5 Key Trends
6. Global Tumor Ablation Market Analysis and Forecast by Disease Indication
6.1 Key Findings
6.2 Introduction
6.3 Market Size (US$ Mn) Forecast, By Disease Indication
6.3.1 Liver cancer
6.3.2 Lung cancer
6.3.3 Kidney cancer
6.3.4 Bone cancer
6.3.5 Breast cancer
6.3.6 Prostate cancer
6.3.7 Others
6.4 Market Attractiveness, By Disease Indication
6.5 Key Trends
7. Global Tumor Ablation Market Analysis and Forecast by End User
7.1 Key Findings
7.2 Introduction
7.3 Market Size (US$ Mn) Forecast, By End User
7.3.1 Home Users
7.3.2 Clinics
7.3.3 Hospitals
7.4 Market Attractiveness, By End User
7.5 Key Trends
8. Global Tumor Ablation Market Analysis and Forecast by Region
8.1 Key Findings
8.2 Introduction
8.2.1 Market Size (US$ Mn) Forecast, By Region
8.2.2 North America
8.2.3 Europe
8.2.4 Asia Pacific
8.2.5 Latin America
8.2.6 Middle East and Africa
9. North America Tumor Ablation Market Analysis and Forecast by Region
9.1 Key Findings
9.2 North America Market Forecast, by Technology
9.3 North America Market Forecast, by Disease Indication
9.4 North America Market Forecast, by End User
9.5 North America Market Forecast, by Country
9.5.1 U.S. Market Overview
9.5.2 Canada Market Overview
9.6 North America Market Attractiveness Analysis
9.7 Market Trends
10. Europe Tumor Ablation Market Analysis and Forecast by Region
10.1 Key Findings
10.2 Europe Market Forecast, by Technology
10.3 Europe Market Forecast, by Disease Indication
10.4 Europe Market Forecast, by End User
10.5 Europe Market Forecast, by Country
10.5.1 U.K. Market Overview
10.5.2 Germany Market Overview
10.5.3 France Market Overview
10.5.4 Italy Market Overview
10.5.5 Spain Market Overview
10.5.6 Russia Market Overview
10.5.7 Rest of Europe Market Overview
10.6 Europe Market Attractiveness Analysis
10.7 Market Trends
11. Asia Pacific Tumor Ablation Market Analysis and Forecast by Region
11.1 Key Findings
11.2 Asia Pacific Market Forecast, by Technology
11.3 Asia Pacific Market Forecast, by Disease Indication
11.4 Asia Pacific Market Forecast, by End User
11.5 Asia Pacific Market Forecast, by Country
11.5.1 India Market Overview
11.5.2 China Market Overview
11.5.3 Japan Market Overview
11.5.4 Australia of Asia Pacific Tumor Ablation Market Overview
11.5.5 Rest of APAC Tumor Ablation Market Overview
11.6 Asia Pacific Market Attractiveness Analysis
11.7 Market Trends
12 Latin America Tumor Ablation Market Analysis and Forecast by Region
12.1 Key Findings
12.2 Latin America Market Forecast, by Technology
12.3 Latin America Market Forecast, by Disease Indication
12.4 Latin America Market Forecast, by End User
12.5 Latin America Market Forecast, by Country
12.5.1 Brazil Tumor Ablation Market Overview
12.5.2 Mexico Tumor Ablation Market Overview
12.5.3 Rest of LATAM Tumor Ablation Market Overview
12.6 Latin America Market Attractiveness Analysis
12.7 Market Trends
13 Middle East and Africa Tumor Ablation Market Analysis and Forecast by Region
13.1 Key Findings
13.2 Middle East and Africa Market Forecast, by Technology
13.3 Middle East and Africa Market Forecast, by Disease Indication
13.4 Middle East and Africa Market Forecast, by End User
13.5 Middle East and Africa Market Forecast, by Country
13.5.1 South Africa Tumor Ablation Market Overview
13.5.2 GCC countries Tumor Ablation Market Overview
13.5.3 Rest of MEA Tumor Ablation Market Overview
13.6 Middle East and Africa Market Attractiveness Analysis
13.7 Market Trends
14. Competitive Landscape
14.1 Market Share Analysis, by Company
14.2 Competition Matrix
14.3 Company Profiles
14.3.1 Medtronic plc.
14.3.1.1 Company Details
14.3.1.2 Business Overview
14.3.1.3 Financial Overview
14.3.1.4 Strategic Overview
14.3.1.5 SWOT Analysis
14.3.2 Integra LifeSciences Holdings Corporation
14.3.2.1 Company Details
14.3.2.2 Business Overview
14.3.2.3 Financial Overview
14.3.2.4 Strategic Overview
14.3.2.5 SWOT Analysis
14.3.3 BTG International Ltd
14.3.3.1 Company Details
14.3.3.2 Business Overview
14.3.3.3 Financial Overview
14.3.3.4 Strategic Overview
14.3.3.5 SWOT Analysis
14.3.4 Boston Scientific Corporation
14.3.4.1 Company Details
14.3.4.2 Business Overview
14.3.4.3 Financial Overview
14.3.4.4 Strategic Overview
14.3.4.5 SWOT Analysis
14.3.5 AngioDynamics, Inc.
14.3.5.1 Company Details
14.3.5.2 Business Overview
14.3.5.3 Financial Overview
14.3.5.4 Strategic Overview
14.3.5.5 SWOT Analysis
14.3.6 SonaCare Medical, LLC.
14.3.6.1 Company Details
14.3.6.2 Business Overview
14.3.6.3 Financial Overview
14.3.6.4 Strategic Overview
14.3.6.5 SWOT Analysis
14.3.7 BVM Medical Limited
14.3.7.1 Company Details
14.3.7.2 Business Overview
14.3.7.3 Financial Overview
14.3.7.4 Strategic Overview
14.3.7.5 SWOT Analysis
14.3.8 St. Jude Medical, Inc.
14.3.8.1 Company Details
14.3.8.2 Business Overview
14.3.8.3 Financial Overview
14.3.8.4 Strategic Overview
14.3.8.5 SWOT Analysis
14.3.9 EDAP TMS S.A.
14.3.9.1 Company Details
14.3.9.2 Business Overview
14.3.9.3 Financial Overview
14.3.9.4 Strategic Overview
14.3.9.5 SWOT Analysis
List of Table
Table 01: Global Tumor Ablation Market Size (US$ Mn) Forecast, By Technology, 2016–2024
Table 02: Global Market Size (US$ Mn) Forecast, By Disease Indication, 2016–2024
Table 03: Global Tumor Ablation Market Size (US$ Mn) Forecast, By End User, 2016–2024
Table 04: Global Tumor Ablation Market Size (US$ Mn) Forecast, By Region Type, 2015–2024
Table 05: North America Tumor Ablation Market Size (US$ Mn) Forecast, By Technology, 2016–2024
Table 06: North America Market Size (US$ Mn) Forecast, By Disease Indication, 2016–2024
Table 07: North America Market Size (US$ Mn) Forecast, By End User, 2016–2024
Table 08: North America Tumor Ablation Market Size (US$ Mn) Forecast, By Country, 2016–2024
Table 09: Europe Tumor Ablation Market Size (US$ Mn) Forecast, By Technology, 2016–2024
Table 10: Europe Market Size (US$ Mn) Forecast, By Disease Indication, 2016–2024
Table 11: Europe Market Size (US$ Mn) Forecast, By End User, 2016–2024
Table 12: Europe Market Size (US$ Mn) Forecast, By Country, 2016–2024
Table 13: Asia Pacific Tumor Ablation Market Size (US$ Mn) Forecast, By Technology, 2016–2024
Table 14: Asia Pacific Market Size (US$ Mn) Forecast, By Disease Indication, 2016–2024
Table 15: Asia Pacific Market Size (US$ Mn) Forecast, By End User, 2016–2024
Table 16: Asia Pacific Market Size (US$ Mn) Forecast, By Country, 2016–2024
Table 17: Latin America Tumor Ablation Market Size (US$ Mn) Forecast, By Technology, 2016–2024
Table 18: Latin America Tumor Ablation Market Size (US$ Mn) Forecast, By Disease Indication, 2016–2024
Table 19: Latin America Tumor Ablation Market Size (US$ Mn) Forecast, By End User, 2016–2024
Table 20: Latin America Market Size (US$ Mn) Forecast, By Country, 2016–2024
Table 21: MEA Tumor Ablation Market Size (US$ Mn) Forecast, By Technology, 2016–2024
Table 22: MEA Market Size (US$ Mn) Forecast, By Disease Indication, 2016–2024
Table 23: MEA Tumor Ablation Market Size (US$ Mn) Forecast, By End User, 2016–2024
Table 24: MEA Market Size (US$ Mn) Forecast, By Country, 2016–2024
List of Figures
Figure 01: Global Tumor Ablation Market Size (US$ Mn) Forecast, 2015–2024
Figure 02: Global Tumor Ablation Market Value Share Analysis by Technology, 2016 and 2024
Figure 03: Global Technology Market Revenue
Figure 04: Global Technology Market Revenue
Figure 05: Global Technology Market Revenue
Figure 06: Global Technology Market Revenue
Figure 07: Global Technology Market Revenue
Figure 08: Global Tumor Ablation Technology Market Revenue
Figure 09: Tumor Ablation Technology Market Attractiveness Analysis by Technology
Figure 10: Global Tumor Ablation Market Value Share Analysis by Disease Indication, 2016 and 2024
Figure 11: Global Tumor Ablation Disease Indication Market Revenue
Figure 12: Global Disease Indication Market Revenue
Figure 13: Global Disease Indication Market Revenue
Figure 14: Global Disease Indication Market Revenue
Figure 15: Global Disease Indication Market Revenue
Figure 16: Global Disease Indication Market Revenue
Figure 17: Global Disease Indication Market Revenue
Figure 18: Tumor Ablation Market Attractiveness Analysis by Disease Indication
Figure 19: Global Tumor Ablation Market Value Share Analysis by End User, 2016 and 2024
Figure 20: Global Home User Tumor Ablation Market Revenue
Figure 21: Global Clinics Tumor Ablation Market Revenue
Figure 22: Global Hospitals Tumor Ablation Market Revenue
Figure 23: Tumor Ablation Market Attractiveness Analysis by End User
Figure 24: Global Tumor Ablation Market Value Share Analysis by Region Type, 2016 and 2024
Figure 25: Tumor Ablation Market Attractiveness Analysis, By Region Type
Figure 26: North America Market Size (US$ Mn) Forecast, 2015–2024
Figure 27: North America Market Attractiveness Analysis by Country
Figure 28: North America Market Value Share Analysis by Technology, 2016 and 2024
Figure 29: North America Market Value Share Analysis by Disease Indication, 2016 and 2024
Figure 30: North America Market Value Share Analysis by End User, 2016 and 2024
Figure 31: North America Market Value Share Analysis by Country, 2016 and 2024
Figure 32: North America Market Attractiveness Analysis, By Disease Indication
Figure 33: North America Market Attractiveness Analysis, By Technology
Figure 34: North America Market Attractiveness Analysis, By End User
Figure 35: Europe Tumor Ablation Market Size (US$ Mn) Forecast, 2015–2024
Figure 36: Europe Market Attractiveness Analysis by Country
Figure 37: Europe Tumor Ablation Market Value Share Analysis by Technology, 2016 and 2024
Figure 38: Europe Tumor Ablation Market Value Share Analysis by Disease Indication, 2016 and 2024
Figure 39: Europe Tumor Ablation Market Value Share Analysis by End User, 2016 and 2024
Figure 40: Europe Market Value Share Analysis by Country, 2016 and 2024
Figure 41: Europe Market Attractiveness Analysis, By Disease Indication
Figure 42: Europe Market Attractiveness Analysis, By Technology
Figure 43: Europe Market Attractiveness Analysis, By End User
Figure 44: Asia Pacific Market Size (US$ Mn) Forecast, 2015–2024
Figure 45: Asia Pacific Market Attractiveness Analysis by Country
Figure 46: Asia Pacific Market Value Share Analysis by Technology, 2016 and 2024
Figure 47: Asia Pacific Tumor Ablation Market Value Share Analysis by Disease Indication, 2016 and 2024
Figure 48: Asia Pacific Market Value Share Analysis by End User, 2016 and 2024
Figure 49: Asia Pacific Market Value Share Analysis by Country, 2016 and 2024
Figure 50: Asia Pacific Market Attractiveness Analysis, By Disease Indication
Figure 51: Asia Pacific Market Attractiveness Analysis, By Technology
Figure 52: Asia Pacific Market Attractiveness Analysis, By End User
Figure 53: Latin America Tumor Ablation Market Size (US$ Mn) Forecast, 2015–2024
Figure 54: Latin America Market Attractiveness Analysis by Country
Figure 55: Latin America Tumor Ablation Market Value Share Analysis by Technology, 2016 and 2024
Figure 56: Latin America Tumor Ablation Market Value Share Analysis by Disease Indication, 2016 and 2024
Figure 57: Latin America Tumor Ablation Market Value Share Analysis by End User, 2016 and 2024
Figure 58: Latin America Market Value Share Analysis by Country, 2016 and 2024
Figure 59: Latin America Market Attractiveness Analysis, By Disease Indication
Figure 60: Latin America Market Attractiveness Analysis, By Technology
Figure 61: Latin America Market Attractiveness Analysis, By End User
Figure 62: MEA Tumor Ablation Market Size (US$ Mn) Forecast, 2015–2024
Figure 63: MEA Market Attractiveness Analysis by Country
Figure 64: MEA Market Value Share Analysis by Technology, 2016 and 2024
Figure 65: MEA Market Value Share Analysis by Disease Indication, 2016 and 2024
Figure 66: MEA Market Value Share Analysis by End User, 2016 and 2024
Figure 67: MEA Market Value Share Analysis by Country, 2016 and 2024
Figure 68: MEA Market Attractiveness Analysis, By Disease Indication
Figure 69: MEA Market Attractiveness Analysis, By Technology
Figure 70: MEA Market Attractiveness Analysis, By End User
Figure 71: Global Tumor Ablation Market Share Analysis by Company (2015)
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
*86 figures and 60 tables includes